Categories
News

The Congolese National Medicines Regulatory Authority (DPM) with WHO to guarantee the development and circulation of safe and effective drugs, by implementing the Global Benchmarking Tool (GBT).

As part of the strengthening of health systems and in particular the regulation of drugs and health products, the headquarters of the World Health Organization (WHO), the WHO Regional Office for Africa (AFRO), and the WHO Country Office (PO) in the Republic of Congo provided technical assistance to support the Directorate of Pharmacy and Medicine (DPM) of Congo from February 15 to 19 2021 in Brazzaville.

The self-assessment of the Directorate of Pharmacy and Medicine (DPM) by the Global Benchmarking Tool (GBT) of the NRAs was initiated at the regional workshop for the harmonization of drug regulation of the Economic and Monetary Community of Central Africa (CEMAC), in February 2020 in Libreville, Gabon. The GBT integrates the Maturity Level (ML) of the various drug regulatory functions in a computerized platform that facilitates its use and the ranking of maturity indicators. This self-assessment has enabled several countries in the sub-region to identify their ML as well as to put in place institutional development plans (IDPs) in order to access a ML which guarantees safety,  quality and effectiveness of drugs in development and in circulation. Click here to for news release in English o in French.

By Dario Scaramuzzi

Pro-bono Partnership & Capacity Development Manager at R-Evolution Worldwide

Leave a Reply

Your email address will not be published. Required fields are marked *